Fostering networking
Connecting digital technology and life sciences communities through national and international partnerships, complemented by joint events that foster knowledge exchange and collaboration.
Trialize AG About association·Chapters·Digital & health technologies
Advancing therapeutic development through digital technologies, data and AI
Starting position
Digital and computational technologies are opening new possibilities across the discovery, development and delivery of therapeutics.
Digital and computational approaches turn complex data into actionable insights and support better-informed decisions in target identification, drug property prediction, personalized treatments, clinical trial optimization and drug repurposing.
Secure, interoperable data infrastructure enables trusted, scalable innovation. Together, these technologies and data ecosystems advance therapeutic development, precision diagnostics and clinically relevant digital solutions.
Vision
The chapter aims to strengthen Switzerland’s position as a leading hub for digital innovation in biotechnology, where digital technologies, data and AI accelerate therapeutic development, inform clinical decisions and contribute to better patient outcomes. By connecting technology developers, biotech companies, researchers and clinical experts, the chapter fosters knowledge exchange and collaboration to drive innovation and the adoption of digital solutions.
Mission
The chapter connects companies, researchers and industry partners across the digital and life sciences communities to foster collaboration, knowledge exchange and commercially relevant innovation. It promotes Swiss expertise and the adoption of digital technologies. Its focus spans target identification and validation, drug property prediction and optimization, precision medicine, clinical trial optimization, computational drug repurposing, and digital companion diagnostics and therapeutics. It also promotes trusted data infrastructure and privacy-preserving collaboration to support the development and adoption of these technologies.
Connecting digital technology and life sciences communities through national and international partnerships, complemented by joint events that foster knowledge exchange and collaboration.
Supporting commercially relevant innovation, sharing market intelligence and connecting digital technologies companies with investors, potential customers and talent.
Serving as a trusted source of information for external stakeholders, while raising the profile of Swiss digital and health technologies and showcasing their contributions to therapeutic innovation through success stories.
Helping shape favorable and competitive framework conditions for digital innovation in biotechnology, including trusted data use, interoperability and the responsible adoption of AI.
Chapter partners
The digital & health technologies chapter is a joint activity of the Swiss Biotech Association and DayOne.
Digital & health technologies in action
Discover selected companies from the chapter and explore how their technologies are advancing therapeutic discovery, development and delivery, from computational drug discovery to precision diagnostics and clinically relevant digital solutions.
Genedata transforms biopharma data into intelligence by combining deep science, technology, and AI domain knowledge. From early discovery to the clinic, the Genedata Biopharma Platform digitalizes and automates complex data workflows, driving innovation and data-based decisions to maximize ROI.
SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 750 institutions in over 70 countries. Our network advances data-driven medicine to improve health outcomes and economics worldwide.
Revolutionizing clinical trials, Trialize's cutting-edge automation platform accelerates study build times by 4x and curbs manual labor by up to 73%, enhancing data quality, patient adherence, and team morale. It's a game-changer in modern, decentralized, and virtual studies.

Showcasing digital & health technologies on a global stage
The Swiss Biotech Day, our flagship annual event and one of the world’s premier biotechnology conferences, offers the digital & health technologies chapter a prominent platform to showcase its innovations, expertise, and industry impact.
Want to showcase your innovations, share your expertise, or expand your network? Companies and experts from the digital & health technologies chapter are invited to express their interest early in sponsorship opportunities, pitching slots, or panel discussions to help shape the chapter program and connect with an international audience.

Highlights from the Swiss Biotech Day 2026
Explore how expert discussions and startup pitches highlighted the role of digital technologies, data and AI in precision oncology and therapeutic development at the Swiss Biotech Day.
Panel discussion: Liquid biopsy at a tipping point in precision oncology. How AI-powered analytics and collaboration are advancing liquid biopsy and precision oncology.
Pitching session: AI-driven breakthroughs from target to therapy. Startups showcased AI, digital twins and engineered biologics in drug development.
Get involved
Companies, researchers and experts working across digital technologies and life sciences are welcome to participate, whether or not they are members of the Swiss Biotech Association.
Exchange expertise, showcase innovations and connect digital technologies with therapeutic development. The chapter’s main stage is the Swiss Biotech Day. Contact the chapter head to:
Keep browsing

Chapter
Developing Swiss industrial biotechnology beyond the biopharmaceutical sector toward a low-carbon, circular economy.
Learn more
About association
Empowering biotechs with cross-industry expertise and dedicated chapters representing key industry segments.
Learn more